AMEKRIN®, AMSIDYL®, AMSIDINE® (AMSACRINE)

Amsacrine is an aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.

Concentrate and solution for concentrate for infusion, solution, 75 mg/1,5 ml.

Pack size: 6 x 75 mg amsacrine

File List (including Summary of Product Characteristics):

Amsacrine Product Monograph (.pdf)

Swedish SPC (.pdf)

German SPC (.pdf)

Belgian SPC (FR) (.pdf)

Belgian SPC (NL) (.pdf)

Belgian SPC (DE) (.pdf)

Dutch SPC (.pdf)

Dutch SPC (EN)  (.pdf)

Irish SPC  (.pdf)

Maltese SPC (EN)  (.pdf)

British SPC  (.pdf)

Austrian SPC  (.pdf)

Czech SPC  (.pdf)

Denmark SPC  (.pdf)

Iceland SPC  (.pdf)

Italian SPC  (.pdf)

Norwegian SPC  (.pdf)

Slovakian SPC  (.pdf)

Finland SPC  (.pdf)

Poland SPC  (.pdf)

Luxembourg SPC (FR)   (.pdf)

Luxembourg SPC (DE)   (.pdf)

Material Safety Data Sheet (.pdf)

Copyright © NordMedica A/S, All Rights Reserved.